Incyte (INCY) Gross Margin (2012 - 2026)

Incyte's (INCY) quarterly Gross Margin came in at 93.73% in Q2 2026, up 21.0% YoY from 77.46% in Q2 2025, and up 2.12% on a QoQ basis from 91.79% in Q1 2026.

Incyte (INCY) Gross Margin (2012 - 2026) Analysis & Trends

Incyte (INCY) has 15 years of Gross Margin data on file, last reported at 93.73% in Q2 2026.

  • Quarterly Gross Margin rose 21.0% year-over-year to 93.73% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 92.62% (down 26.0% YoY) and the FY2025 annual result came in at 92.76%, up 12.0% from the prior year.
  • Gross Margin grew to 93.73% in Q2 2026, from 91.79% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 94.44% in Q2 2022 to a low of 91.79% in Q1 2026.
  • A 5-year average of 93.08% and a median of 93.06% in 2024 frame the typical range for Gross Margin.
  • Annual changes were most pronounced in 2022 — Gross Margin plunged 173 bps — and 2025, when it soared 86 bps.
  • Tracing INCY's Gross Margin over 5 years: stood at 93.62% in 2022, then declined by 1 bps to 93.12% in 2023, then retreated by 1 bps to 92.49% in 2024, then slipped by 1 bps to 91.96% in 2025, then advanced by 2 bps to 93.73% in 2026.
  • The last three Gross Margin figures came in at 93.73% (Q2 2026), 91.79% (Q1 2026), and 91.96% (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 85.33%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 91.59%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 90.68%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 89.76%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 60,631,834.75%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 76.90%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 84.20%
10 Incyte 24.15 Bn 19.61 Bn 1.57 Bn 93.73%

Historic Data

Download Data
DateValue
Jun 30, 2026 93.73%
Mar 31, 2026 91.79%
Dec 31, 2025 91.96%
Sep 30, 2025 92.75%
Jun 30, 2025 93.52%
Mar 31, 2025 93.05%
Dec 31, 2024 92.49%
Sep 30, 2024 92.44%
Jun 30, 2024 92.66%
Mar 31, 2024 93.08%
Dec 31, 2023 93.12%
Sep 30, 2023 93.46%
Jun 30, 2023 92.84%
Mar 31, 2023 92.97%
Dec 31, 2022 93.62%
Sep 30, 2022 93.37%
Jun 30, 2022 94.44%
Mar 31, 2022 94.19%
Dec 31, 2021 94.92%
Sep 30, 2021 95.10%